
Rojelio Mejia MD
Assistant Professor, Medicine, Baylor Coll of Med
Join to view full profile
1709 Dryden Rd# 620Houston, TX 77030
Phone+1 713-798-9121
Dr. Mejia is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 2008 - 2012
University of Virginia Medical CenterResidency, Internal Medicine, 2006 - 2008
Michigan State University College of Human MedicineClass of 2006
Certifications & Licensure
TX State Medical License 2012 - 2027
VA State Medical License 2006 - 2012
Publications & Presentations
PubMed
- Bacterial fecal microbiome composition associated with HIV stage among rural and peri-urban adults living with HIV in Uganda.Bożena M Morawski, Elise R Morton, Miya Yunus, Claudia Muñoz-Zanzi, Rojelio Mejia
BMC Infectious Diseases. 2026-03-10 - 1 citationsDistribution of nematophagous fungi and soil-transmitted helminths in outdoor built environments across Latin America.Rojelio Mejia, Eva Mereles Aranda, Leticia Ojeda, Sandra Ocampos Benedetti, Janitzio J Guzman
Plos Neglected Tropical Diseases. 2026-02-01 - Molecular surveillance of intestinal parasites and Acanthamoeba species in soils from outdoor built environments in rural northwestern Argentina.María Cristina Almazán, Melisa Evangelina Díaz-Fernández, Elvia Ester Nieves, Marisa Juárez, Lucia Estela Mejia
Parasite. 2026-01-01
Press Mentions
Infrastructure Neglect and Poverty Lead to Parasites in the Mississippi DeltaJanuary 1st, 2025
‘People Should Be Aware’: Eggs of Tiny Infectious Worm Found in Parks in New York and EuropeJune 30th, 2022
Billionaire Mark Cuban’s New Drug Company Is Producing Low-Cost Generic Drugs Cutting 90% of the MarkupJanuary 29th, 2021
Grant Support
- Evaluation of a novel Tc-24 ELISA test in post-treatment efficacy for Chagas disease.BAYLOR COLLEGE OF MEDICINE2025–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: